Portfolio company
ChemT Biotechnology
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops AI-designed small molecules to enhance biologics production and cell productivity for pharmaceutical and biotechnology manufacturers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
Chemify
This company provides automated molecular design and synthesis services to pharmaceutical, biotechnology and industrial partners using robotics and artificial intelligence.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
Dogma Biotech
This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
